Ten selected startups pitched at our June Symposium: the 2017 Rosenman Innovators. These early-stage companies were vetted by our judges and received introductions to industry partners and accredited investors, as well as in-kind services from a range of providers in the medical device industry. Details on the Innovator Program
2017 Rosenman Innovators
AesculaTech engages in the development and manufacture of a platform of devices for the treatment of diseases for the eye.
First gas-based therapy for fungal nail infections. We are a 5 person team of very experienced technicians. Our medical device prototype is currently in two ongoing clinical trials.
Intelligent Implants: Bioelectronic implants electrically stimulating controlled bone and tissue healing.
2016 Rosenman Innovators
Individualized assistive robotic devices for rehabilitation and daily assistance
A preclinical company in cell therapy device production, with a validated thin film cell encapsulation technology that protects transplanted therapeutic cells
A novel device that protects and stabilizes the umbilical catheter in neonates to ensure security of the lifeline and reduce the rate of umbilical cord-associated bloodstream infections